The European Medicines Agency's committee has recommended approval of French drugmaker Sanofi's first-of-its-kind drug that ...

The EMA’s recommendation follows evidence that the targeted therapy improves progression-free survival in patients whose ...

Regulators upheld their earlier decision after reexamination, saying the substance does not meet the criteria for new active ...

Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development.

The inequitable distribution of vaccines during the COVID-19 pandemic was the final proof of the need for more home-grown ...

Research on adults who take S.S.R.I.s shows they tamp down sexual desire. Why aren’t we studying what that could mean for ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company") today reported that it has received approval to Start Phase II ...

During a meeting this week, an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed 10 new ...

Shortly after crossing the FDA’s finish line, Ionis Pharmaceuticals’ RNA-targeted hereditary angioedema (HAE) treatment ...

Anavex Life Sciences (AVXL) stock falls as the company faces a potential failure to win EU approval for its Alzheimer’s ...

Scholar Rock soared by 24.41 percent on Friday to close at $37.41 apiece as investor sentiment was boosted by the progress of ...

Company reports $14.3 million in revenue in Q3’25, consisting of $3.6 million in YCANTH® revenue and $10.7 million of license and ...